Clinical Trials
12
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study
- Conditions
- Atopic DermatitisEczema
- Interventions
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Kymab Limited
- Target Recruit Count
- 390
- Registration Number
- NCT05131477
- Locations
- 🇺🇸
Investigative Site Number: 1018, Fremont, California, United States
🇺🇸Investigative site #1022, Sacramento, California, United States
🇺🇸Investigative Site Number: 1006, Boca Raton, Florida, United States
A Study of Subcutaneous KY1005 in Healthy Volunteers
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Kymab Limited
- Target Recruit Count
- 24
- Registration Number
- NCT04449939
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Conditions
- Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular CarcinomaEsophageal CancerGastric CancerMelanomaRenal Cell CarcinomaPancreatic CancerCervical CancerTriple Negative Breast Cancer
- Interventions
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Kymab Limited
- Target Recruit Count
- 222
- Registration Number
- NCT03829501
- Locations
- 🇺🇸
Kymab investigational site 1109, Duarte, California, United States
🇺🇸Kymab investigational site 1102, New Haven, Connecticut, United States
🇺🇸Kymab investigational site 1108, Orlando, Florida, United States
A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2023-01-27
- Lead Sponsor
- Kymab Limited
- Target Recruit Count
- 89
- Registration Number
- NCT03754309
- Locations
- 🇩🇪
Kymab investigational site 106, Kiel, Germany
🇩🇪Kymab investigational site 113, Leipzig, Germany
🇵🇱Kymab investigational site 207, Gdansk, Poland
A Study of KY1005 in Healthy Volunteers
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Kymab Limited
- Target Recruit Count
- 64
- Registration Number
- NCT03161288
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands